HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.

Abstract
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a distinct low-grade lymphoma that often regresses upon Helicobacter pylori eradication. It was reported that the chemokine receptor CXCR3 is expressed not only on activated T cells, but also on MALT lymphoma cells, and that CXCR3-positive B lymphocytes migrate or home to the MALT of MALT lymphoma. In the present study, we aimed to elucidate the correlation between CXCR3 expression and the clinicopathological features of gastric MALT lymphoma, and to determine whether CXCR3 expression was predictive of responsiveness to H. pylori eradication. Sixty-seven patients with gastric MALT lymphoma in a single-center study were treated with H. pylori eradication therapy. We evaluated the correlation of CXCR3 expression with response to H. pylori eradication therapy by logistic regression stratified according to potential confounders. Immunohistochemical analysis revealed that 28 of 67 cases (42%) were positive for CXCR3 expression. CXCR3 expression was significantly more prevalent in those without H. pylori infection, advanced-stage disease, and in those with API2-MALT1 fusion. In overall analysis, those with CXCR3 expression showed a significantly increased risk of non-responsiveness to H. pylori eradication therapy (odds ratio = 28.6; 95% confidence interval 5.70-143.4) compared to those without CXCR3 expression. This higher risk was observed consistently regardless of sex, API2-MALT1 fusion, H. pylori infection, or clinical stage. We showed that CXCR3 expression was an independent predictive factor for non-responsiveness to H. pylori eradication therapy in patients with gastric MALT lymphoma.
AuthorsHideko Yamamoto, Tsuneya Nakamura, Keitaro Matsuo, Masahiro Tajika, Hiroki Kawai, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto, Shigeo Nakamura
JournalCancer science (Cancer Sci) Vol. 99 Issue 9 Pg. 1769-73 (Sep 2008) ISSN: 1349-7006 [Electronic] England
PMID18616679 (Publication Type: Journal Article)
Chemical References
  • CXCR3 protein, human
  • Receptors, CXCR3
Topics
  • Female
  • Forecasting
  • Gene Expression
  • Helicobacter Infections (genetics)
  • Helicobacter pylori
  • Humans
  • Immunohistochemistry
  • Lymphoma, B-Cell, Marginal Zone (genetics, pathology)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Receptors, CXCR3 (metabolism)
  • Risk Assessment
  • Stomach Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: